Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

May Mo

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Biometrics|September 27, 2024
Rejoinder to the discussion on "LEAP: the latent exchangeability prior for borrowing information from historical data"Ethan M Alt, Xiuya Chang, Xun Jiang, et al.
Lupus Science & Medicine|July 25, 2023
Improving resource utilisation in SLE drug development through innovative trial designSandra Garces, Elaine Karis, Joan T Merrill, et al.
Statistics in Medicine|March 14, 2020
Network meta-regression for ordinal outcomes: Applications in comparing Crohn's disease treatmentsYeongjin Gwon, May Mo, Ming-Hui Chen, et al.
Journal of the American Academy of Dermatology|December 15, 2018
Tezepelumab, an anti-thymic stromal lymphopoietin monoclonal antibody, in the treatment of moderate to severe atopic dermatitis: A randomized phase 2a clinical trialEric L Simpson, Jane R Parnes, Dewei She, et al.
The New England Journal of Medicine|September 7, 2017
Tezepelumab in Adults with Uncontrolled AsthmaJonathan Corren, Jane R Parnes, Liangwei Wang, et al.
Clinical Colorectal Cancer|April 10, 2010
A randomized, placebo-controlled phase ii study evaluating the reduction of neutropenia and febrile neutropenia in patients with colorectal cancer receiving pegfilgrastim with every-2-week chemotherapyJ Randolph Hecht, Madhavan Pillai, Russell Gollard, et al.
Respiratory Research|October 14, 2020
SOURCE: a phase 3, multicentre, randomized, double-blind, placebo-controlled, parallel group trial to evaluate the efficacy and safety of tezepelumab in reducing oral corticosteroid use in adults with oral corticosteroid dependent asthmaMichael E Wechsler, Gene Colice, Janet M Griffiths, et al.
Respiratory Research|October 14, 2020
NAVIGATOR: a phase 3 multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the efficacy and safety of tezepelumab in adults and adolescents with severe, uncontrolled asthmaAndrew Menzies-Gow, Gene Colice, Janet M Griffiths, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 15, 2011
Palifermin reduces severe mucositis in definitive chemoradiotherapy of locally advanced head and neck cancer: a randomized, placebo-controlled studyQuynh-Thu Le, Harold E Kim, Charles J Schneider, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Biometrics|September 27, 2024
Rejoinder to the discussion on "LEAP: the latent exchangeability prior for borrowing information from historical data"Ethan M Alt, Xiuya Chang, Xun Jiang, et al.
Lupus Science & Medicine|July 25, 2023
Improving resource utilisation in SLE drug development through innovative trial designSandra Garces, Elaine Karis, Joan T Merrill, et al.
Statistics in Medicine|March 14, 2020
Network meta-regression for ordinal outcomes: Applications in comparing Crohn's disease treatmentsYeongjin Gwon, May Mo, Ming-Hui Chen, et al.
Journal of the American Academy of Dermatology|December 15, 2018
Tezepelumab, an anti-thymic stromal lymphopoietin monoclonal antibody, in the treatment of moderate to severe atopic dermatitis: A randomized phase 2a clinical trialEric L Simpson, Jane R Parnes, Dewei She, et al.
The New England Journal of Medicine|September 7, 2017
Tezepelumab in Adults with Uncontrolled AsthmaJonathan Corren, Jane R Parnes, Liangwei Wang, et al.
Clinical Colorectal Cancer|April 10, 2010
A randomized, placebo-controlled phase ii study evaluating the reduction of neutropenia and febrile neutropenia in patients with colorectal cancer receiving pegfilgrastim with every-2-week chemotherapyJ Randolph Hecht, Madhavan Pillai, Russell Gollard, et al.
Respiratory Research|October 14, 2020
SOURCE: a phase 3, multicentre, randomized, double-blind, placebo-controlled, parallel group trial to evaluate the efficacy and safety of tezepelumab in reducing oral corticosteroid use in adults with oral corticosteroid dependent asthmaMichael E Wechsler, Gene Colice, Janet M Griffiths, et al.
Respiratory Research|October 14, 2020
NAVIGATOR: a phase 3 multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the efficacy and safety of tezepelumab in adults and adolescents with severe, uncontrolled asthmaAndrew Menzies-Gow, Gene Colice, Janet M Griffiths, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 15, 2011
Palifermin reduces severe mucositis in definitive chemoradiotherapy of locally advanced head and neck cancer: a randomized, placebo-controlled studyQuynh-Thu Le, Harold E Kim, Charles J Schneider, et al.
Pageof 2